ApexTradeZ commented on a stock · Apr 17, 2024 05:56

Final Stretch -into 4/26 AH Approval

👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervant for adults and pediatric together just by themselves this is HUGE - don’t Fool yourself and Miss this boat!!!

there is a plethera of addironal reasons to buy and long term HOLD AQST - Alpha is giving you a chance to WIN BIG ‼️⭐️🫵🏻💯💵👈🏻

$Jaguar Health (JAGX.US)$ $Viking Therapeutics (VKTX.US)$ $X4 Pharmaceuticals (XFOR.US)$ $Day One Biopharmaceuticals (DAWN.US)$ $Tesla (TSLA.US)$